Evidence map›Paper›PMID 18074226›Full record

ReviewHeart failure reviews2008

Noninvasive imaging of apoptosis in cardiovascular disease.

Ethan Chauncey Korngold, Farouc Amin Jaffer, Ralph Weissleder, David Edwin Sosnovik

Open access · greenAbstract readReview
In one paragraph

Review in Heart failure reviews, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Estrone-salicylaldehyde N-methylated thiosemicarbazone hybrids and their copper complexes: solution structure, stability and anticancer activity in tumour spheroids.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2021
    Article
  3. Review
  4. Article
  5. Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation.American journal of nuclear medicine and molecular imaging · 2018
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Protective effect of the apoptosis-sensing nanoparticle AnxCLIO-Cy5.5.Nanomedicine : nanotechnology, biology, and medicine · 2012
    Article
  12. From molecules to myofibers: multiscale imaging of the myocardium.Journal of cardiovascular translational research · 2011
    Review
  13. Article
  14. Article
  15. Small-animal SPECT and SPECT/CT: application in cardiovascular research.European journal of nuclear medicine and molecular imaging · 2010
    Review
  16. Review
  17. Article
  18. Article
  19. A DNA-binding Gd chelate for the detection of cell death by MRI.Chemical communications (Cambridge, England) · 2009
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ethan Chauncey KorngoldCenter for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, 149 13th St., 5th floor, Boston, MA 02129, USA.
Farouc Amin Jaffer
Ralph Weissleder
David Edwin Sosnovik
Gordon Center for Medical Imaging · USHarvard University · US

Funding

Translational Program of Excellence in NanotechnologyU01HL080731 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2005 to 2009
$14.9M
Magnetic Resonance Imaging of Cardiomyocyte ApoptosisK08HL079984 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SOSNOVIK, DAVID E · 2005 to 2009
$661k
NHLBI NIH HHS K08 HL079984NHLBI NIH HHS U01 HL080731NHLBI NIH HHS UO1-HL080731
6 · The paper itself

Abstract

Recent advances in molecular imaging have permitted the noninvasive imaging of apoptosis, a critical process underlying the pathogenesis of many diseases of the cardiovascular system including atherosclerotic vascular disease, myocardial ischemia and reperfusion injury, chronic heart failure, myocarditis, and cardiac allograft rejection. Multiple molecular targets including phosphatidylserine, phosphatidylinositol 3-kinase, and caspases have been targeted by a variety of imaging agents and modalities such as nuclear scintigraphy, PET, MRI, and fluorescent and bioluminescent imaging. Translationally, methods utilizing radiolabeled annexin V have proven promising in several clinical trials of ischemia-reperfusion injury and cardiac allograft rejection. New approaches using novel molecular imaging agents show great potential for the ability to image apoptosis in the research and clinical setting. Ultimately the ability to detect apoptosis noninvasively would help to identify patients for emerging anti-apoptotic therapies and guide clinical management with the aim of maximal myocardial preservation.

Indexed as

ApoptosisAnimalsCardiovascular DiseasesHumansMagnetic Resonance ImagingMyocytes, CardiacSeverity of Illness IndexTomography, Emission-Computed, Single-Photon

Identifiers

PMID18074226
PMCPMC2597223
OpenAlexW1997934908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.